ArticlePloS one2018

Molecular prediction of adjuvant cisplatin efficacy in Non-Small Cell Lung Cancer (NSCLC)-validation in two independent cohorts.

Ida Kappel Buhl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.